Northern New England Clinical Oncology Society

Home
Membership

Join

Renew

Corporate Membership
Education

2021 Annual Meeting

Annual Meeting Abstracts

Abstract Travel Grants

2021 Virtual Spring Meeting

2021 Spring Meeting Abstracts

2021 Spring Accepted Abstracts

OCN-Agenda

Lunchtime Best Oncology Practice Series

Regional Educational Programs
FUNDING

Research Funding

Student Project Funding

Funded Projects

Educational Program Grants

Presenter/Topic List

ASCO NNECOS Awards
Philanthropy

NNECOS Helps

Cancer Community Support

Stowe Weekend of Hope

Conquer Cancer, the ASCO Foundation
Advocacy
News

NNECOS News

National Topics & Updates

NH Oral Parity

Oral Parity Status Update

NNECOS Supports IDEA
Resources

Drug Related Resources

Regional Reimbursement Contacts

Patient Access Programs

FDA Approvals

Code Updates

Packaging/Label Updates

Other Updates

COVID-19 Updates

Safety Updates

Member Resources

NNECOS Classifieds

Member Practices

Our member directory

Legislative Contact Information

Other Resources

Community Resources

Cancer Community Center

Healing Arts Program

On-Belay

Magnolia Meals at Home

Thank You Supporters

MACRA

Patient Navigation Resources
About Us

Leadership

Board

Fellow Liaisons

Election

Nominations

Nomination Form

NAHPAC

Our Vision

Why NNECOS?

NNECOS History

Historical Project: Clinical Trials Barrier Study

Historical Project: Oncology Care in Rural Northern New England

Strategic Plan

NNECOS & ASCO

Contact us

NNECOS Contact List

Board Committees & Representation

The mission of NNECOS is to promote the highest quality care for patients with cancer and blood disorders in our region through professional networking, education, and scientific research, as well as patient advocacy and public policy.

NNECOS BOARD OF DIRECTORS ELECTION

Attention Active Members: Vote by September 21st! Learn more on our Election page.

CANCER COMMUNITY SUPPORT

NNECOS Helps

Please read this special message to our community.

NNECOS News

Industry-Sponsored Regional Education & Initiatives

Sep 23 - Taiho Oncology dinner program on Lonsurf®

Details on our Regional Educational Programs Page

Latest FDA Approvals And Drug-Related Updates

Latest FDA Approvals

Aug 13 - FDA approves belzutifan for cancers associated with von Hippel-Lindau disease
Aug 17 - FDA grants accelerated approval to dostarlimab-gxly for dMMR advanced solid tumors
Aug 19 - FDA approves nivolumab for adjuvant treatment of urothelial carcinoma
Aug 25 - FDA approves ivosidenib for advanced or metastatic cholangiocarcinoma
Aug 31 - FDA approves zanubrutinib for Waldenström’s macroglobulinemia
Sep 14 - FDA grants accelerated approval to zanubrutinib for marginal zone lymphoma
Sep 15 - FDA grants accelerated approval to mobocertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations

Package/Label Updates

Code Updates

Oct 1 - J-code J9247 for Pepaxto® (melphalan flufenamide) injection, 1mg.

Other Updates

New Job Posted - NNECOS Classifieds

Northern Light Health Eastern Maine Medical Center is seeking a board-certified/board eligible hematologist/oncologist
UVM Medical Center is seeking a physician with experience in hematologic malignancies, autologous stem cell transplantation and CAR-T cell therapy
Multiple Positions - New England Cancer Specialists Maine & New Hampshire

COVID SURVEY AND RESOURCES

ASCO Survey on COVID in Oncology Registry

The aim is to help the cancer community learn more about the patterns of symptoms & severity of COVID among patients with cancer, as well as the impact on delivery of cancer care & patient outcomes. Periodic reports will deliver real-time information to the oncology community.